Evidence map›Paper›PMID 29333567›Full record

ArticleTranslational stroke research2018

Predictors for Intracranial Hemorrhage Following Intravenous Thrombolysis in Posterior Circulation Stroke.

Tomáš Dorňák, Michal Král, Zuzana Sedláčková, Daniel Šaňák, Eva Čecháková, Petra Divišová, Jana Zapletalová, Petr Kaňovský

Erratum issuedAbstract read
PubMed Publisher
In one paragraph

Article in Translational stroke research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. CD4Oxidative medicine and cellular longevity · 2021
    Article
  9. Article
  10. Frontiers in neurology · 2019
    Article
  11. Review
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Tomáš DorňákComprehensive Stroke Center, Department of Neurology, Palacký University and University Hospital Olomouc, I. P. Pavlova 6, CZ-775 20, Olomouc, Czech Republic. dornaktomas@seznam.cz.ORCID 0000-0002-5111-3617
Michal KrálComprehensive Stroke Center, Department of Neurology, Palacký University and University Hospital Olomouc, I. P. Pavlova 6, CZ-775 20, Olomouc, Czech Republic.
Zuzana SedláčkováComprehensive Stroke Center, Department of Radiology, Palacký University and University Hospital Olomouc, Olomouc, Czech Republic.
Daniel ŠaňákComprehensive Stroke Center, Department of Neurology, Palacký University and University Hospital Olomouc, I. P. Pavlova 6, CZ-775 20, Olomouc, Czech Republic.
Eva ČechákováComprehensive Stroke Center, Department of Radiology, Palacký University and University Hospital Olomouc, Olomouc, Czech Republic.
Petra DivišováComprehensive Stroke Center, Department of Neurology, Palacký University and University Hospital Olomouc, I. P. Pavlova 6, CZ-775 20, Olomouc, Czech Republic.
Jana ZapletalováDepartment of Medical Biophysics, Palacký University, Olomouc, Czech Republic.
Petr KaňovskýComprehensive Stroke Center, Department of Neurology, Palacký University and University Hospital Olomouc, I. P. Pavlova 6, CZ-775 20, Olomouc, Czech Republic.
University Hospital Olomouc · CZPalacký University Olomouc · CZ

Funding

Ministerstvo Zdravotnictví Ceské Republiky (CZ) 15-31921AMinisterstvo Zdravotnictví Ceské Republiky (CZ) 17-29452AMinisterstvo Zdravotnictví Ceské Republiky (CZ) 17-30101A
6 · The paper itself

Abstract

Intravenous thrombolysis (IVT) is a standard treatment for anterior (ACS) and posterior circulation stroke (PCS). However, due to the low occurrence of PCS and of intracranial hemorrhage (ICH) in PCS, the knowledge about ICH predictors following IVT in PCS is sparse. Our aim was to identify predictors for ICH following IVT in PCS. The set consisted of 1281 consecutive ischemic stroke (IS) patients treated with IVT, out of which 158 (103 males; mean age 65.6 ± 12.3 years) had PCS. Collected data include baseline characteristics, common stroke risk factors, pre-medication, stroke severity, admission blood glucose level, blood pressure and treatment with intravenous antihypertensive therapy before and during IVT, occlusion of arteries, recanalization rate, time to treatment, and clinical outcome at day 90. Overall, 11 (7%) patients had ICH. Atrial fibrillation (p = 0.004), neurological deficit at time of treatment in the National Institutes of Health Stroke Scale (p = 0.016), decreased level of consciousness (p = 0.003), occlusion of basilar artery (p = 0.007), occlusion of PCA (p = 0.001), and additional endovascular therapy (p = 0.001) were identified by logistic regression analysis as significant predictors for ICH in PCS. Patients with ischemic lesion in the brainstem, occlusion of vertebral artery, or absence of basilar and posterior cerebral artery occlusion might be considered for treatment with IVT even in borderline cases. Those patients seem to have less frequently favorable outcomes without an increase in ICH rate. Time to IVT in PCS seems not to influence ICH risk or chances for favorable outcomes as significantly as it does in ACS.

Indexed as

Administration, IntravenousAgedAged, 80 and overBrain IschemiaFemaleFibrinolytic AgentsHumansIntracranial HemorrhagesMagnetic Resonance AngiographyMagnetic Resonance ImagingMaleMiddle AgedPredictive Value of TestsRetrospective StudiesStrokeTissue Plasminogen ActivatorFibrinolytic AgentsTissue Plasminogen ActivatorIntracranial hemorrhageIntravenous thrombolysisIschemic strokePosterior circulation

Identifiers

PMID29333567
OpenAlexW2784019187

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.